Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 83 results

Search term: MF = 'C_{28}H_{32}ClN_{3}O_{6}'
12345
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
571012

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C28H31N3O6.ClH/c1-18-24(27(32)36-3)26(21-11-7-12-22(15-21)31(34)35)25(19(2)29-18)28(33)37-23-13-8-14-30(17-23)16-20-9-5-4-6-10-20;/h4-7,9-12,15,23,26,29H,8,13-14,16-17H2,1-3H3;1H/t23-,26-;/m1./s1
C28H32ClN3O6542.02318645800
110323

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C28H31N3O6.ClH/c1-18-24(27(32)36-3)26(21-11-7-12-22(15-21)31(34)35)25(19(2)29-18)28(33)37-23-13-8-14-30(17-23)16-20-9-5-4-6-10-20;/h4-7,9-12,15,23,26,29H,8,13-14,16-17H2,1-3H3;1H
C28H32ClN3O6542.0231799999993395780
28290668

1 of 2 defined stereocentres - 1/2 defined
InChI=1/C28H31N3O6.ClH/c1-18-24(27(32)36-3)26(21-11-7-12-22(15-21)31(34)35)25(19(2)29-18)28(33)37-23-13-8-14-30(17-23)16-20-9-5-4-6-10-20;/h4-7,9-12,15,23,26,29H,8,13-14,16-17H2,1-3H3;1H/t23-,26?;/m1./s1
C28H32ClN3O6542.0232141300
2344856

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C28H31N3O6.ClH/c1-18-24(27(32)36-3)26(21-11-7-12-22(15-21)31(34)35)25(19(2)29-18)28(33)37-23-13-8-14-30(17-23)16-20-9-5-4-6-10-20;/h4-7,9-12,15,23,26,29H,8,13-14,16-17H2,1-3H3;1H/t23-,26-;/m0./s1
C28H32ClN3O6542.0231799999999600
21562642

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C28H32ClN3O6/c1-36-22-5-2-4-20(16-22)27(35)32-24(25(33)30-17-23-6-3-15-37-23)18-38-28(32)11-13-31(14-12-28)26(34)19-7-9-21(29)10-8-19/h2,4-5,7-10,16,23-24H,3,6,11-15,17-18H2,1H3,(H,30,33)
C28H32ClN3O6542.02327600
23089409

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C28H31N3O6.ClH/c1-18-24(27(32)36-3)26(21-12-9-13-22(16-21)31(34)35)25(19(2)29-18)28(33)37-23-14-7-8-15-30(23)17-20-10-5-4-6-11-20;/h4-6,9-13,16,23,26,29H,7-8,14-15,17H2,1-3H3;1H
C28H32ClN3O6542.023268780
31066888

Charge
InChI=1/C28H32N3O2.ClHO4/c1-4-32-26-11-7-23(8-12-26)25-19-22(3)31(17-6-16-30-18-15-29-21-30)28(20-25)24-9-13-27(14-10-24)33-5-2;2-1(3,4)5/h7-15,18-21H,4-6,16-17H2,1-3H3;(H,2,3,4,5)/q+1;/p-1
C28H32ClN3O6542.02326400
31045453

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C28H31N3O6.ClH/c1-18-24(27(32)36-3)26(21-11-7-12-22(15-21)31(34)35)25(28(33)37-23-13-8-14-29-16-23)19(2)30(18)17-20-9-5-4-6-10-20;/h4-7,9-12,15,23,26,29H,8,13-14,16-17H2,1-3H3;1H/t23-,26-;/m0./s1
C28H32ClN3O6542.02325300
49132
InChI=1/C21H26ClN3O3.C7H6O3/c1-24(2)14-12-23-20(26)11-13-25(18-6-4-5-17(22)15-18)21(27)16-7-9-19(28-3)10-8-16;8-6-4-2-1-3-5(6)7(9)10/h4-10,15H,11-14H2,1-3H3,(H,23,26);1-4,8H,(H,9,10)
C28H32ClN3O6542.0231799999994200
50645163

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C28H31N3O6.ClH/c1-18-24(27(32)36-3)26(21-11-7-12-22(15-21)31(34)35)25(28(33)37-23-13-8-14-29-16-23)19(2)30(18)17-20-9-5-4-6-10-20;/h4-7,9-12,15,23,26,29H,8,13-14,16-17H2,1-3H3;1H/t23-,26-;/m1./s1
C28H32ClN3O6542.02324300
68394675

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C28H32ClN3O6/c1-31(18-21-6-4-3-5-7-21)27(34)17-28(20-36-23-10-8-22(29)9-11-23)19-32(14-15-37-28)26(33)13-12-24-16-25(35-2)30-38-24/h3-11,16H,12-15,17-20H2,1-2H3
C28H32ClN3O6542.02324300
84428480

Double-bond stereo
InChI=1/C28H31N3O2.ClHO4/c1-7-33-26-13-9-12-24(30-25-15-18(3)17(2)14-23(25)29)27-19(4)31(20(5)28(26)27)21-10-8-11-22(16-21)32-6;2-1(3,4)5/h8-16H,7,29H2,1-6H3;(H,2,3,4,5)/b30-24+;
C28H32ClN3O6542.02324300
107447107

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C28H31N3O6.ClH/c1-18-24(27(32)36-3)26(21-11-7-12-22(15-21)31(34)35)25(19(2)29-18)28(33)37-23-13-8-14-30(17-23)16-20-9-5-4-6-10-20;/h4-7,9-12,15,23,26,29H,8,13-14,16-17H2,1-3H3;1H/t23-,26+;/m1./s1
C28H32ClN3O6542.02324300
21561816

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C28H32ClN3O6/c1-36-22-9-7-19(8-10-22)27(35)32-24(25(33)30-17-23-6-3-15-37-23)18-38-28(32)11-13-31(14-12-28)26(34)20-4-2-5-21(29)16-20/h2,4-5,7-10,16,23-24H,3,6,11-15,17-18H2,1H3,(H,30,33)
C28H32ClN3O6542.02323200
76727816

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C28H32ClN3O6/c1-30-13-12-26(33)31(28(30)36)14-15-38-24-11-6-19(16-25(24)37-2)18-32(22-4-3-5-22)23(17-27(34)35)20-7-9-21(29)10-8-20/h6-13,16,22-23H,3-5,14-15,17-18H2,1-2H3,(H,34,35)
C28H32ClN3O6542.02323300
76815213

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C28H32ClN3O6/c1-30-12-11-26(33)32(28(30)36)13-14-38-24-10-5-20(15-25(24)37-2)18-31(17-19-3-4-19)23(16-27(34)35)21-6-8-22(29)9-7-21/h5-12,15,19,23H,3-4,13-14,16-18H2,1-2H3,(H,34,35)
C28H32ClN3O6542.02323300
34234562

Double-bond stereo

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C28H31N3O6.ClH/c1-18-24(27(32)36-3)26(21-11-7-12-22(15-21)31(34)35)25(19(2)29-18)28(33)37-23-13-8-14-30(17-23)16-20-9-5-4-6-10-20;/h4-7,9-12,15,23,26,33H,8,13-14,16-17H2,1-3H3;1H/b28-25+;/t23-,26-;/m1./s1
C28H32ClN3O6542.02323200
34246154

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C28H32ClN3O6/c1-4-7-23(31-13-6-9-19(16-31)32-15-17(2)26(33)30-28(32)36)21-11-12-22(27(34)35)25(24(21)37-3)38-20-10-5-8-18(29)14-20/h5,8,10-12,14-15,19,23H,4,6-7,9,13,16H2,1-3H3,(H,34,35)(H,30,33,36)/t19-,23+/m0/s1
C28H32ClN3O6542.02322200
34246155

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C28H32ClN3O6/c1-4-7-23(31-13-6-9-19(16-31)32-15-17(2)26(33)30-28(32)36)21-11-12-22(27(34)35)25(24(21)37-3)38-20-10-5-8-18(29)14-20/h5,8,10-12,14-15,19,23H,4,6-7,9,13,16H2,1-3H3,(H,34,35)(H,30,33,36)/t19-,23-/m0/s1
C28H32ClN3O6542.02322200
4197515
InChI=1/C28H32ClN3O6/c1-36-25-17-20(16-24(29)30-25)27(35)31-10-7-28(8-11-31)9-12-32(18-28)26(34)6-4-21(33)19-3-5-22-23(15-19)38-14-2-13-37-22/h3,5,15-17H,2,4,6-14,18H2,1H3
C28H32ClN3O6542.0231799999992100
12345

Advertisement